Tech Company Financing Transactions
Lynx Funding Round
Flare Capital Partners, .406 Ventures and CVS Health Ventures participated in a $27 million Series A venture round for Lynx. This venture round was announced on 2/7/2025.
Transaction Overview
Company Name
Announced On
2/7/2025
Transaction Type
Venture Equity
Amount
$27,000,000
Round
Series A
Investors
Flare Capital Partners (Lead Investor) (Victor Lanio)
Proceeds Purpose
The company intends to use the funds to: Further enhance innovation in Medicare Advantage supplemental benefits, Medicaid value-added benefits, and ICHRA. Enhance Consumer -- Directed Health (CDH) account administration and compliance capabilities for health plans and financial institutions. Develop API-driven products to streamline the consumer experience and operations for benefits administrators and health plans.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
Avenida de Cantabria Station Boadilla del Monte
Madrid, 28660
ES
Madrid, 28660
ES
Phone
Undisclosed
Website
Email Address
Overview
Lynx was born to lead the fight against Fraud and Financial Crime through advanced AI Technologies, continuous innovation and deep industry expertise.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dan Dica
Browse more venture capital transactions:
Prev: 2/7/2025: Mantle8 venture capital transaction
Next: 2/7/2025: Hiveclass venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs